First class action filed over Shkreli’s price-hike of Daraprim
Blue Cross and Blue Shield of Minnesota has sued former pharmaceutical company executive Martin Shkreli over his alleged scheme to monopolise the market for antiparasitic drug Daraprim.
Subscribe to Global Competition Review
Subscribe and start reading now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10